click below
click below
Normal Size Small Size show me how
diabetes meds
| Question | Answer |
|---|---|
| Pioglitazone(Actos®) •Rosiglitazone(Avandia®) | Thiazolidinediones |
| Increases tissue sensitivity reducing insulin resistance | Thiazolidinediones MOA |
| Repaglinide (Gluconorm®) | Meglitinides |
| metabolized by CYP450 high potential for drug-drug interactions stimulates the pancreatic beta cells to release insulin | Meglitinides MOA |
| Acarbose(Glucobay®) | Alpha-Glucosidase Inhibitors |
| delays the absorption of carbohydrates, reduces peak plasma glucose levels, does not promote insulin secretion | Alpha-Glucosidase Inhibitors MOA |
| Metformin(Glucophage®) | Biguanides |
| Increases peripheral glucose uptake and Helps the body use sugar better reduces insulin resistance Slows glucose absorption | Biguanides MOA |
| •Glyburide-Diabeta® •Gliclazide-Diamicron® •Glipizide •Glimepiride-Amaryl® | Sulfonylureas |
| Stimulate insulin release from pancreatic beta cells and decrease glycogenolysis, which is the breakdown of glycogen into glucose. | Sulfonylureas MOA |
| Insulin Lispro (Humalog), Insulin Aspart (Novolog), Insulin Glulisine (Apidra) | Rapid-acting insulin: Starts within 15 mins, peaks in 30-90 mins, lasts 3-5 hrs; for mealtime |
| (Humulin R, Novolin R) | Short-Acting (Regular): Starts in 30 mins, peaks in 2-3 hrs, lasts 6-8 hrs; also for meals. |
| Long-Acting: Starts in 1-2 hrs, provides steady coverage for ~24 hrs | Insulin Detemir (Levemir), Insulin Glargine (Lantus, Basaglar) |
| Alogliptin (Brand name: Nesina®) Linagliptin (Brand name: Tradjenta®) Saxagliptin (Brand name: Onglyza®) Sitagliptin (Brand name: Januvia®) Vildagliptin (Brand name: Galvus®) | Dipeptidyl Peptidase-4 (DPP-4) Inhibitors |
| preventing the breakdown of incretin hormones (GLP-1 and GIP). | Dipeptidyl Peptidase-4 (DPP-4) Inhibitors -liptin MOA |
| lower blood sugar by blocking glucose reabsorption in the kidney, forcing glucose to be excreted in urine. - Urinary tract infections are common | Sodium-glucose cotransporter-2 (SGLT2) inhibitors MOA |
| Canagliflozin(Invokana®) •Dapagliflozin(Forxiga®) •Empagliflozin(Jardiance®) | Sodium-glucose cotransporter-2 (SGLT2) inhibitors |
| Dulaglutide(Trulicity®)-onceweekly •Liraglutide(Victoza®)-oncedaily •Lixisenatide(Adlyxin®)-oncedaily •Semaglutide(Ozempic®)-onceweekly | Incretin Mimetics / Glucagon-like peptide-1 (GLP-1) receptor agonists - |
| Stimulating insulin release (beta cells). Suppressing glucagon (alpha cells). Slowing gastric emptying. Reducing appetite. | Incretin Mimetics / Glucagon-like peptide-1 (GLP-1) receptor agonists -MOA |
| Pramlintide (Symlin)+ Cagrilintide | Amylin Analog |
| Colesevelam | cholesterol-lowering agent (a bile acid sequestrant). It can modestly improve blood glucose levels in type 2 diabetes. |
| Bromocriptine | Dopamine agonist: improve glycemic control |
| slows gastric emptying, suppressing inappropriate glucagon secretion (reducing liver glucose production), and increasing satiety | AMYLIN ANALOG MOA |